Regeneron Pharmaceuticals (REGN) Convertible Debt (2011 - 2015)
Regeneron Pharmaceuticals (REGN) posted quarterly Convertible Debt of $30.7 million for Q3 2015, down 89.33% year-over-year from $288.0 million in Q3 2014, and up 1.2% quarter-over-quarter from $30.4 million in Q2 2015.
Regeneron Pharmaceuticals (REGN) Convertible Debt (2011 - 2015) Analysis & Trends
Regeneron Pharmaceuticals' Convertible Debt history runs 5 years deep, the most recent figure standing at $30.7 million for Q3 2015.
- In Q3 2015, Convertible Debt fell 89.33% year-over-year to $30.7 million; the TTM figure through Sep 2015 stood at $30.7 million (down 89.33% YoY), while the FY2014 annual figure was $146.8 million, down 54.18% from the prior year.
- Convertible Debt for Q3 2015 stood at $30.7 million, up from $30.4 million in the prior quarter.
- The five-year high for Convertible Debt was $326.7 million in Q1 2014, with the low at $30.4 million in Q2 2015.
- The 5-year median for Convertible Debt is $286.7 million (2012), against an average of $245.1 million.
- The sharpest annual moves came in 2014 and 2015: Convertible Debt rose 8.07% in 2014, then plunged 89.33% in 2015.
- Regeneron Pharmaceuticals' Convertible Debt stood at $275.0 million in 2011, then gained by 7.82% to $296.5 million in 2012, then increased by 8.03% to $320.3 million in 2013, then tumbled by 54.18% to $146.8 million in 2014, then sank by 79.07% to $30.7 million in 2015.
- Business Quant data shows REGN's Convertible Debt at $30.7 million in Q3 2015, $30.4 million in Q2 2015, and $144.1 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 30.72 Mn |
| Jun 30, 2015 | 30.36 Mn |
| Mar 31, 2015 | 144.08 Mn |
| Dec 31, 2014 | 146.77 Mn |
| Sep 30, 2014 | 287.95 Mn |
| Jun 30, 2014 | 282.26 Mn |
| Mar 31, 2014 | 326.67 Mn |
| Dec 31, 2013 | 320.32 Mn |
| Sep 30, 2013 | 314.16 Mn |
| Jun 30, 2013 | 308.12 Mn |
| Mar 31, 2013 | 302.27 Mn |
| Dec 31, 2012 | 296.52 Mn |
| Sep 30, 2012 | 290.96 Mn |
| Jun 30, 2012 | 285.49 Mn |
| Mar 31, 2012 | 280.21 Mn |
| Dec 31, 2011 | 275.02 Mn |